PROCOS S.P.A. (CBC Group)
Kingo Yamashita has extensive experience in the commercial sector, currently serving as a Member of the Board and Chief Commercial Officer at PROCOS S.P.A. since April 2019, along with the role of Executive Officer at CBC Co., Ltd. Additionally, Kingo has held various positions at Procos SpA (CBC Group) since September 2006, including Sales & Marketing Director and Member of the Board. Previous experience includes serving as Chemical Division Manager at CBC (EUROPE) Ltd from April 2004 to August 2006. Kingo Yamashita holds a degree from Tokyo University of Pharmacy and Life Sciences, earned between 1989 and 1992.
PROCOS S.P.A. (CBC Group)
Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry. Our core business sectors include custom synthesis and Generic API manufacturing. The manufacturing site is located in Cameri, Italy. This 110,000 sq. meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA. We are a locally rooted company yet part of an international network, with commercial offices in key strategic geographies.